Screening performance for trisomy 21 comparing first trimester combined screening and a first trimester contingent screening protocol including ductus venosus and tricuspid flow.

about

First-trimester ultrasound screening for trisomy 21 based on maternal age, fetal nuchal translucency, and different methods of ductus venosus assessment.The Danish Fetal Medicine Database: revealing the fruits of collaborative research.

P2860

Q47375200-228CFF23-A2CA-46EB-8602-720DCD7CA88F Q50567110-37A49AFF-0E8B-444F-8BE1-D802D3632B9A

P2860

Screening performance for trisomy 21 comparing first trimester combined screening and a first trimester contingent screening protocol including ductus venosus and tricuspid flow.

Item

http://www.wikidata.org/entity/Q51366811

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Screening performance for tris ...... us venosus and tricuspid flow.

@en

Screening performance for tris ...... us venosus and tricuspid flow.

@nl

type

Item

label

Screening performance for tris ...... us venosus and tricuspid flow.

@en

Screening performance for tris ...... us venosus and tricuspid flow.

@nl

prefLabel

Screening performance for tris ...... us venosus and tricuspid flow.

@en

Screening performance for tris ...... us venosus and tricuspid flow.

@nl

P1476

Screening performance for tris ...... us venosus and tricuspid flow.

@en

P2093

A Tabor

http://www.w3.org/2001/XMLSchema#string

C K Ekelund

http://www.w3.org/2001/XMLSchema#string

F H Pedersen

http://www.w3.org/2001/XMLSchema#string

K Sundberg

http://www.w3.org/2001/XMLSchema#string

P2860

Impact of a new national screening policy for Down's syndrome in Denmark: population based cohort study.

Promises and pitfalls of first trimester sonographic markers in the detection of fetal aneuploidy.

Additional first-trimester ultrasound markers.

Tricuspid regurgitation in the diagnosis of chromosomal anomalies in the fetus at 11-14 weeks of gestation.

Analysis of secondary ultrasound markers in the first trimester before chorionic villus sampling.

First-trimester screening for chromosomal abnormalities by integrated application of nuchal translucency, nasal bone, tricuspid regurgitation and ductus venosus flow combined with maternal serum free β-hCG and PAPP-A: a 5-year prospective study.

Ductus venosus Doppler in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation.

Tricuspid regurgitation in screening for trisomies 21, 18 and 13 and Turner syndrome at 11+0 to 13+6 weeks of gestation.

Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: relationship with nuchal translucency measurement and fetal outcome.

Screening for chromosomal abnormalities at 10-14 weeks: the role of ductus venosus blood flow

P304

783-788

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PD.3902

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Olav B. Petersen

Ida Vogel

P577

2012-05-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224979431

http://www.w3.org/2001/XMLSchema#string

P698

22605406

http://www.w3.org/2001/XMLSchema#string

Screening performance for trisomy 21 comparing first trimester combined screening and a first trimester contingent screening protocol including ductus venosus and tricuspid flow.

about

P2860

P2860

Screening performance for trisomy 21 comparing first trimester combined screening and a first trimester contingent screening protocol including ductus venosus and tricuspid flow.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698